Natural Alternatives International (NAII) risk factors, FY2024 10-K

Natural Alternatives International's FY2024 10-K, filed Sep 27, 2024, lists 22 risk factors in 7 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
227 groups
Section length
6k wordsItem 1A

Natural Alternatives International's biggest risks in the FY2024 10-K

  • Concentrated customer base creates extreme dependency risk, with three customers accounting for 68% of consolidated net sales.
  • Single-source supply chain vulnerability exists for beta-alanine used in CarnoSyn products.
  • Extensive government regulations govern nutritional supplement manufacturing, packaging, and labeling across global markets.

The risks most specific to Natural Alternatives International

  • Risks Related to Operations, Manufacturing, and Technology

    The failure of our suppliers to supply quality materials in sufficient quantities, at a favorable price, and in a timely fashion could adversely affect the results of our operations

    We purchase all of our beta-alanine for our CarnoSyn, SR CarnoSyn, and TriBsyn products from a single manufacturer in Japan, and one raw material supplier represented over 10% of our purchases in fiscal 2024.

  • Risks Related to Customer Concentration

    Because we derive a significant portion of our revenues from a limited number of customers, our revenues would be adversely affected by the loss of a major customer or a significant change in their business, personnel or the timing or amount of their sales to their customers and their orders from us

    Sales to our three largest customers accounted for approximately 68% of our consolidated net sales during the fiscal year ended June 30, 2024.

  • Risks Related to Operations, Manufacturing, and Technology

    Our manufacturing and third party fulfillment activities are subject to certain risks

    We manufacture the majority of our products at facilities located in California and Switzerland, making us dependent on their uninterrupted operation.

  • Risks Related to Insider Ownership and Corporate Structure

    Collectively, our officers and directors own a significant amount of our common stock, giving them influence over corporate transactions and other matters and potentially limiting the influence of other stockholders on important policy and management issues

    Our CEO Mark LeDoux, his family, and affiliates beneficially own approximately 16% of our common stock, with total officers and directors owning 21%.

  • Risks Related to Future Acquisitions

    We expect our operating results will vary. Fluctuations in our operating results may adversely affect the share price of our common stock

    We experienced a net loss and decreased net sales during fiscal 2024 compared to fiscal 2023, and may incur losses in the future.

  • Risks Related to Regulations

    Possible new tariffs on imported goods from China and elsewhere could adversely affect our business operations

    Tariffs on goods imported from China and elsewhere could increase costs for products and ingredients like beta-alanine.

All 22 risk factors

Headings as the filing states them, in filing order.

Risks Related to the Company’s Industry and Business

  1. 01A significant or prolonged economic downturn, could have, a material adverse effect on our results of operations
  2. 02Risks related to global economic instability, including global supply chain issues, inflation and fuel and energy costs may affect the Company's business
  3. 03Our industry is highly competitive, and we may be unable to continue to compete effectively. Increased competition could adversely affect our financial condition
  4. 04Our business is subject to the effects of adverse publicity, which could negatively affect our sales and revenues

Risks Related to Operations, Manufacturing, and Technology

  1. 05If we are unable to attract and retain qualified management personnel, and key manufacturing personnel, our business may suffer
  2. 06Our manufacturing and third party fulfillment activities are subject to certain risks
  3. 07currency transfer and other restrictions and regulations that may limit our ability to sell certain products or repatriate profits to the U.S
  4. 08The failure of our suppliers to supply quality materials in sufficient quantities, at a favorable price, and in a timely fashion could adversely affect the results of our operations

Risks Related to Customer Concentration

  1. 09Because we derive a significant portion of our revenues from a limited number of customers, our revenues would be adversely affected by the loss of a major customer or a significant change in their business, personnel or the timing or amount of their sales to their customers and their orders from us
  2. 10Our future growth and stability depends, in part, on our ability to diversify our sales. Our efforts to establish new sales from both existing customers and new customers could require significant initial investments, which may or may not result in higher overall sales and improved financial results

Risks Related to Regulations

  1. 11Our products and manufacturing activities are subject to extensive government regulation, which could limit or prevent the sale of our products in some markets and could increase our costs
  2. 12Possible new tariffs on imported goods from China and elsewhere could adversely affect our business operations

Risks Related to Litigation

  1. 13We could be exposed to product liability claims or other litigation, which may be costly and could materially adversely affect our operations
  2. 14We may continue to incur significant costs in the course of creating and defending our intellectual property. We may be unable to protect our intellectual property rights or may inadvertently infringe on the intellectual property rights of others

Risks Related to Insider Ownership and Corporate Structure

  1. 15If certain provisions of our Certificate of Incorporation, Bylaws and Delaware law are triggered, the market for our shares may decrease
  2. 16Collectively, our officers and directors own a significant amount of our common stock, giving them influence over corporate transactions and other matters and potentially limiting the influence of other stockholders on important policy and management issues

Risks Related to Future Acquisitions

  1. 17We may pursue acquisitions of other companies that, if not successful, could adversely affect our business, financial condition and results of operations
  2. 18potential impairment charges, which may be significant, against goodwill and purchased intangible assets acquired in an acquisition due to changes in conditions and circumstances that occur after the acquisition, many of which may be outside of our control
  3. 19We expect our operating results will vary. Fluctuations in our operating results may adversely affect the share price of our common stock
  4. 20Our stock price could fluctuate significantly
  5. 21our and our customers’ and suppliers’ products and other public announcements
  6. 22We may not be able to raise additional capital or obtain additional financing if needed

Other Natural Alternatives International 10-Ks

  • FY2026 10-K risk factors
    22 risks3 new4 reworded

    Three years of losses and negative cash flow now create substantial doubt about NAII’s ability to continue as a going concern.

    Filed Sep 28, 2026
  • FY2025 10-K risk factors
    22 risks3 reworded

    Operating loss increased in fiscal 2025 despite higher net sales. The company shifted its fiscal 2026 profit outlook, expecting a first-half loss and second-half net income. Geopolitical risk disclosures now explicitly include the Middle East alongside Ukraine.

    Filed Sep 23, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.